Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 2
1988 1
1989 1
1991 1
1992 1
1993 3
1994 4
1995 4
1996 4
1997 5
1998 3
1999 6
2000 6
2001 2
2002 5
2003 12
2004 4
2005 5
2006 5
2007 13
2008 13
2009 20
2010 20
2011 24
2012 34
2013 34
2014 29
2015 44
2016 50
2017 45
2018 59
2019 74
2020 91
2021 79
2022 86
2023 50
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

741 results

Results by year

Filters applied: . Clear all
Page 1
Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms.
van Weelden G, Bobiński M, Okła K, van Weelden WJ, Romano A, Pijnenborg JMA. van Weelden G, et al. Mar Drugs. 2019 Jan 7;17(1):32. doi: 10.3390/md17010032. Mar Drugs. 2019. PMID: 30621045 Free PMC article. Review.
However, the exact mechanism of action is currently unknown. Therefore, this review will address fucoidans structure, the bioavailability, and all known different pathways affected by fucoidan, in order to formulate fucoidans structure and activity in relatio …
However, the exact mechanism of action is currently unknown. Therefore, this review will address fucoidans structure, the bioavailabi …
Therapeutic Effects of Fucoidan: A Review on Recent Studies.
Luthuli S, Wu S, Cheng Y, Zheng X, Wu M, Tong H. Luthuli S, et al. Mar Drugs. 2019 Aug 21;17(9):487. doi: 10.3390/md17090487. Mar Drugs. 2019. PMID: 31438588 Free PMC article. Review.
Fucoidan is a polysaccharide largely made up of l-fucose and sulfate groups. ...More recently, a variety of in vitro and in vivo studies have been carried out to further highlight its therapeutic potentials. This review focuses on the progress towards understanding fuco
Fucoidan is a polysaccharide largely made up of l-fucose and sulfate groups. ...More recently, a variety of in vitro and in vivo stud
Fucoidan Ameliorated Dextran Sulfate Sodium-Induced Ulcerative Colitis by Modulating Gut Microbiota and Bile Acid Metabolism.
Liu X, Zhang Y, Li W, Zhang B, Yin J, Liuqi S, Wang J, Peng B, Wang S. Liu X, et al. J Agric Food Chem. 2022 Nov 30;70(47):14864-14876. doi: 10.1021/acs.jafc.2c06417. Epub 2022 Nov 15. J Agric Food Chem. 2022. PMID: 36378195
Our results showed that fucoidan effectively suppressed colonic inflammation and repaired the gut barrier. ...Collectively, these findings provided the basis for fucoidan as a potential functional food for colitis....
Our results showed that fucoidan effectively suppressed colonic inflammation and repaired the gut barrier. ...Collectively, these fin …
Fucoidan-based nanoparticles: Preparations and applications.
Venkatesan J, Murugan SS, Seong GH. Venkatesan J, et al. Int J Biol Macromol. 2022 Sep 30;217:652-667. doi: 10.1016/j.ijbiomac.2022.07.068. Epub 2022 Jul 13. Int J Biol Macromol. 2022. PMID: 35841962 Review.
Nanoparticle-based therapy has gained much attention in the pharmaceutical industry. ...Hence, fucoidan-based nanoparticles have been helpful for biomedical applications....
Nanoparticle-based therapy has gained much attention in the pharmaceutical industry. ...Hence, fucoidan-based nanoparticles ha …
Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis.
Shih PH, Shiue SJ, Chen CN, Cheng SW, Lin HY, Wu LW, Wu MS. Shih PH, et al. Mar Drugs. 2021 Mar 12;19(3):148. doi: 10.3390/md19030148. Mar Drugs. 2021. PMID: 33809062 Free PMC article. Clinical Trial.
Here, we investigated the feasibility of combinatorial effects of low molecular weight fucoidan and high stability fucoxanthin (LMF-HSFx) as a therapeutic approach against NAFLD. ...
Here, we investigated the feasibility of combinatorial effects of low molecular weight fucoidan and high stability fucoxanthin (LMF-H …
Fucoidan: Biological Activity in Liver Diseases.
Li J, Guo C, Wu J. Li J, et al. Am J Chin Med. 2020;48(7):1617-1632. doi: 10.1142/S0192415X20500809. Epub 2020 Nov 5. Am J Chin Med. 2020. PMID: 33148007 Review.
Fucoidan is a type of polysaccharide rich in sulfuric acid groups and is mainly found in brown algae. Due to its extensive biological activities, such as anticoagulant, antitumor, antithrombotic, antiviral, anti-oxidant and enhancing immune function, fucoidan has gr
Fucoidan is a type of polysaccharide rich in sulfuric acid groups and is mainly found in brown algae. Due to its extensive biological
The Use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: A Double-Blinded Study.
Post GS, Lustgarten J. Post GS, et al. Top Companion Anim Med. 2022 Jan-Feb;46:100616. doi: 10.1016/j.tcam.2021.100616. Epub 2021 Dec 2. Top Companion Anim Med. 2022. PMID: 34864255
We evaluated the effect of oligo fucoidan (Laminina Japonica) derived from oceanic brown seaweed on the quality of life in dogs with cancer undergoing chemotherapy in a double-blinded case control study. ...There were minimal adverse side effects of giving the oligo …
We evaluated the effect of oligo fucoidan (Laminina Japonica) derived from oceanic brown seaweed on the quality of life in dogs with …
Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer.
Huang CW, Chen YC, Yin TC, Chen PJ, Chang TK, Su WC, Ma CJ, Li CC, Tsai HL, Wang JY. Huang CW, et al. Int J Mol Sci. 2021 Jul 27;22(15):8041. doi: 10.3390/ijms22158041. Int J Mol Sci. 2021. PMID: 34360807 Free PMC article.
This study investigated the roles of low-molecular-weight fucoidan (LMWF) in enhancing the anti-cancer effects of fluoropyrimidine-based chemotherapy. ...Our results demonstrated that LMWF is a potential complementary therapy for enhancing the efficacies of f …
This study investigated the roles of low-molecular-weight fucoidan (LMWF) in enhancing the anti-cancer effects of fluoropyrimidine-ba …
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis.
Klettner A. Klettner A. Mar Drugs. 2016 Feb 3;14(2):31. doi: 10.3390/md14020031. Mar Drugs. 2016. PMID: 26848666 Free PMC article. Review.
However, the possible usage of fucoidan in ophthalmological diseases has received little attention so far. In this review, biological activities of fucoidan that could be of interest regarding these diseases will be discussed....
However, the possible usage of fucoidan in ophthalmological diseases has received little attention so far. In this review, biological …
Fucoidan for cardiovascular application and the factors mediating its activities.
Yao Y, Yim EKF. Yao Y, et al. Carbohydr Polym. 2021 Oct 15;270:118347. doi: 10.1016/j.carbpol.2021.118347. Epub 2021 Jun 18. Carbohydr Polym. 2021. PMID: 34364596 Free PMC article. Review.
Fucoidan is a sulfated polysaccharide with various bioactivities. The application of fucoidan in cancer treatment, wound healing, and food industry has been extensively studied. However, the therapeutic value of fucoidan in cardiovascular diseases has been le
Fucoidan is a sulfated polysaccharide with various bioactivities. The application of fucoidan in cancer treatment, wound heali
741 results